Misspecified proportional hazard models

From MaRDI portal
Publication:3745117

DOI10.1093/biomet/73.2.363zbMath0606.62108OpenAlexW2065787672MaRDI QIDQ3745117

Cyntha A. Struthers, John D. Kalbfleisch

Publication date: 1986

Published in: Biometrika (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1093/biomet/73.2.363



Related Items

On an extension of the promotion time cure model, Z-estimation and stratified samples: application to survival models, Does Cox analysis of a randomized survival study yield a causal treatment effect?, Balancing Unobserved Covariates With Covariate-Adaptive Randomized Experiments, The covariance adjustment approaches for combining incomparable Cox regressions caused by unbalanced covariates adjustment: a multivariate meta-analysis study, Sequential tests for non-proportional hazards data, Robust inference for univariate proportional hazards frailty regression models, Erosion of Regression Effect in a Survival Study, Practical methods for competing risks data: A review, Measurement Error in Covariates in the Marginal Hazards Model for Multivariate Failure Time Data, Estimation and inference of predictive discrimination for survival outcome risk prediction models, Regression analysis of additive hazards model with sparse longitudinal covariates, Effects of model misspecification in estimating covariate effects in survival analysis for small sample sizes, A Statistical Issue About a Phase III Multi-regional Trial for the Survival Data under Accelerated Failure Time Model with Unrecognized Heterogeneity, Generalized martingale-residual processes for goodness-of-fit inference in Cox's type regression models, Intention-to-treat comparisons in randomized trials, Model selection among dimension-reduced generalized Cox models, Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark, Doubly robust estimator for net survival rate in analyses of cancer registry data, A corrected profile likelihood method for survival data with covariate measurement error under the Cox model, Maximum Likelihood Estimation in the Additive Hazards Model, Robustness and efficiency of Sasieni-type estimators in the Cox model., Effect of Covariate Omission in Randomised Controlled Trials: A Review and Simulation Study, Nonproportional hazards model with a frailty term for modeling subgroups with evidence of long‐term survivors: Application to a lung cancer dataset, Combining primary cohort data with external aggregate information without assuming comparability, Restricted mean survival time as a function of restriction time, Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets, Analysis and asymptotic theory for nested case-control designs under highly stratified proportional hazards models, Cox regression can be collapsible and aalen regression can be non-collapsible, Comment on: ``Models as (deliberate) approximations, Additive Bayesian variable selection under censoring and misspecification, Assumption-Lean Cox Regression, On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects, The impacts of unobserved covariates on covariate-adaptive randomized experiments, Rank-Based Greedy Model Averaging for High-Dimensional Survival Data, Proportional hazards models based on biased samples and estimated selection probabilities, On proportional hazards assumption under the random effects models, Relatives' risks: Frailty models of life history data, Unnamed Item, A class of proportional win‐fractions regression models for composite outcomes, Robust Covariate‐Adjusted Log‐Rank Statistics and Corresponding Sample Size Formula for Recurrent Events Data, Estimating hazard ratios in cohort data with missing disease information due to death, Multistate life‐tables and regression models, Prognostic score matching methods for estimating the average effect of a non-reversible binary time-dependent treatment on the survival function, Simpson's Paradox in Survival Models, Time-dependent covariates in the proportional subdistribution hazards model for competing risks, Inference for proportional hazard model with propensity score, Double‐Robust Semiparametric Estimator for Differences in Restricted Mean Lifetimes in Observational Studies, Least squares type estimation for Cox regression model and specification error, A Note on Using Regression Models to Analyze Randomized Trials: Asymptotically Valid Hypothesis Tests Despite Incorrectly Specified Models, Estimation of Main Effect When Covariates Have Non-Proportional Hazards, SmoothHR: an R package for pointwise nonparametric estimation of hazard ratio curves of continuous predictors, On Robustness and Model Flexibility in Survival Analysis: Transformed Hazard Models and Average Effects, Asymptotic distributions of two ``synthetic data estimators for censored single-index models, Predictive capability of stratified proportional hazards models, Adaptive Neyman's smooth tests of homogeneity of two samples of survival data, On the random effects Cox model with time-varying regression parameter, Some properties of misspecified additive hazards models, Nonparametric inference under a monotone hazard ratio order, Implications of model misspecification in robust tests for recurrent events, A Note on the Estimate of Treatment Effect from a Cox Regression Model When the Proportionality Assumption Is Violated, The Mizon–Richard Encompassing Test for the Cox and Aalen Additive Hazards Models, Parameter estimation of partial linear model under monotonicity constraints with censored data, Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study, Survival Analysis with Time-Varying Regression Effects Using a Tree-Based Approach, A Semiparametric Estimate of Treatment Effects with Censored Data, The Use of Frailty Hazard Models for Unrecognized Heterogeneity That Interacts with Treatment: Considerations of Efficiency and Power, Weighted least squares estimators in possibly misspecified nonlinear regression, Score tests for independence in semiparametric competing risks models, Dynamic path analysis for event time data: large sample properties and inference, Joint covariate-adjusted score test statistics for recurrent events and a terminal event, Estimation of treatment effects based on possibly misspecified Cox regression, Robust inference in discrete hazard models for randomized clinical trials, Robust sandwich covariance estimation for regression calibration estimator in Cox regression with measurement error., Flexible hazard ratio curves for continuous predictors in multi-state models, Unobserved confounder effects in models for clustered dental failure time data, Nonparametric estimation of a regression function from backward recurrence times in a cross-sectional sampling, Effect of Berkson measurement error on parameter estimates in Cox regression models, Reducing bias in parameter estimates from stepwise regression in proportional hazards regression with right-censored data, Principled sure independence screening for Cox models with ultra-high-dimensional covariates, Impact of covariate omission and categorization from the Fine-Gray model in randomized-controlled trials, Oracle inequalities for weighted group Lasso in high-dimensional misspecified Cox models, Weighted Lindley frailty model: estimation and application to lung cancer data, Correcting the results of the wrong model: treatment effects under early detection of cancer, Optimal robust influence functions in semiparametric regression, Robust inference for the proportional hazards model with two-phase cohort sampling data, Marker-dependent observation and carry-forward of internal covariates in Cox regression, Robust prediction of the cumulative incidence function under non‐proportional subdistribution hazards, A note on the robust interpretation of regression coefficients, Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored, The issue about sample size for survival analysis considering the interaction of unrecognized heterogeneity and treatment, An issue about the efficacy for the time-to-event outcome based on accelerated failure time model with interaction of unrecognized heterogeneity and main effect